Moscow (Russian Federation).- (FILE) – A Russian medical worker displays a trial vaccine against COVID-19 in a post-registration phase of the test at outpatient hospital number 68 in Moscow, Russia, 17 September 2020. Russia registered the new vaccine called ‘Sputnik V’ against Coronavirus Sars-Cov-2 and opened the stage of its massive testing (reissued 24 November 2020). AFP reports on 24 November 2020 developers of Sputnik V vaccine saying the vaccine being 95 per cent effective. The statement follows the interim second analysis by developers of trial information. (Abierto, Rusia, Moscú) EFE/EPA/SERGEI ILNITSKY *** Local Caption *** 56349350
